Seminars in Oncology
Volume 35, Issue 2 , Pages 183-191, April 2008

Diagnosis and Management of Peritoneal Carcinomatosis Arising From Adenocarcinoma of the Colon and Rectum

  • Richard E. Royal
  • ,
  • James F. Pingpank Jr

      Affiliations

    • Corresponding Author InformationAddress correspondence to James F. Pingpank Jr, MD, Surgical Metabolism Section, Surgery Branch, NCI, NIH, CRC, Building 10, Room 4W-5932, 10 Center Dr, MSC-1201, Bethesda, MD 20892.

Surgical Metabolism Section, Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Peritoneal carcinomatosis (the implantation of tumor cells throughout the peritoneal cavity) occurs in as many as 50% of patients with colorectal cancer and in up to 25% is the only site of recurrence. There is increasing evidence that aggressive debulking of peritoneal only disease followed by intraperitoneal chemotherapy can have significant impact on the patient’s quality and sometimes quantity of life. This chapter will provide an overview of the biologic basis of pathogenesis and the treatment of peritoneal metastases from colorectal cancer.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0093-7754(07)00276-X

doi:10.1053/j.seminoncol.2007.12.007

Seminars in Oncology
Volume 35, Issue 2 , Pages 183-191, April 2008